New research has found that over 1,100 people in the UK develop lung cancer each year due to air pollution, with the most common subtype, adenocarcinoma, linked to toxic air exposure.

Air pollution might be playing an increasing role in causing the disease.

High School hockey team took on teams from three states during the first week of February. It culminated with a 4-2 loss to ...

Zydus Lifesciences subsidiary has partnered with Zhuhai Beihai Biotech to market a cancer drug, Beizray (Albumin Solubilized ...

Zydus Lifesciences' subsidiary partners with Zhuhai Beihai Biotech to market Beizray, a cancer drug, in the US. Zhuhai will ...

Researchers at Oregon Health and Science University (OHSU) have developed a blood test called PAC-MANN, to detect pancreatic ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 ...

Ipsen SA (IPSEF) reports robust financial performance with a 9.9% sales increase and strategic pipeline developments, despite ...

Six people die in a fire in Busan, South Korea; Lung cancer cases spike in China, probably due to pollution; Pakistan is once again hosting a major international cricket to ...

Ipsen expects total sales growth of more than 5% at constant exchange rates in 2025, supported by the continued expansion of products like IQIRVO, ONIVYDE, and Bylvay. However, Somatuline faces ...

RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, highlighted its ...